These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 26567591)

  • 41. A novel approach to enhance the mucoadhesion of lipid drug nanocarriers for improved drug delivery to the buccal mucosa.
    Du JD; Liu Q; Salentinig S; Nguyen TH; Boyd BJ
    Int J Pharm; 2014 Aug; 471(1-2):358-65. PubMed ID: 24879939
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Characterization of a Liquid Crystal System for Sustained Release of a Peptide BMS-686117.
    Xu Y; Li V; Li J; Pan D; Langenbucher G; Mathias N
    AAPS PharmSciTech; 2018 Jan; 19(1):348-357. PubMed ID: 28741139
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Liquid crystalline systems of phytantriol and glyceryl monooleate containing a hydrophilic protein: Characterisation, swelling and release kinetics.
    Rizwan SB; Hanley T; Boyd BJ; Rades T; Hook S
    J Pharm Sci; 2009 Nov; 98(11):4191-204. PubMed ID: 19340889
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Rationalizing the selection of oral lipid based drug delivery systems by an in vitro dynamic lipolysis model for improved oral bioavailability of poorly water soluble drugs.
    Dahan A; Hoffman A
    J Control Release; 2008 Jul; 129(1):1-10. PubMed ID: 18499294
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Bicontinuous cubic liquid crystals as sustained delivery systems for peptides and proteins.
    Rizwan SB; Boyd BJ; Rades T; Hook S
    Expert Opin Drug Deliv; 2010 Oct; 7(10):1133-44. PubMed ID: 20858165
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Gastric pre-processing is an important determinant of the ability of medium-chain lipid solution formulations to enhance oral bioavailability in rats.
    Lee KW; Porter CJ; Boyd BJ
    J Pharm Sci; 2013 Nov; 102(11):3957-65. PubMed ID: 23983139
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Lipid-based formulations for oral administration of poorly water-soluble drugs.
    Mu H; Holm R; Müllertz A
    Int J Pharm; 2013 Aug; 453(1):215-24. PubMed ID: 23578826
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Prediction of oral absorption of cinnarizine--a highly supersaturating poorly soluble weak base with borderline permeability.
    Berlin M; Przyklenk KH; Richtberg A; Baumann W; Dressman JB
    Eur J Pharm Biopharm; 2014 Nov; 88(3):795-806. PubMed ID: 25195981
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Revisiting dispersible milk-drug tablets as a solid lipid formulation in the context of digestion.
    Binte Abu Bakar SY; Salim M; Clulow AJ; Hawley A; Boyd BJ
    Int J Pharm; 2019 Jan; 554():179-189. PubMed ID: 30391337
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A study of microemulsions as prolonged-release injectables through in-situ phase transition.
    Wu Z; Alany RG; Tawfeek N; Falconer J; Zhang W; Hassan IM; Rutland M; Svirskis D
    J Control Release; 2014 Jan; 174():188-94. PubMed ID: 24316265
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Investigating the correlation between in vivo absorption and in vitro release of fenofibrate from lipid matrix particles in biorelevant medium.
    Borkar N; Xia D; Holm R; Gan Y; Müllertz A; Yang M; Mu H
    Eur J Pharm Sci; 2014 Jan; 51():204-10. PubMed ID: 24134899
    [TBL] [Abstract][Full Text] [Related]  

  • 52. In vivo study of an instantly formed lipid-water cubic phase formulation for efficient topical delivery of aminolevulinic acid and methyl-aminolevulinate.
    Evenbratt H; Jonsson C; Faergemann J; Engström S; Ericson MB
    Int J Pharm; 2013 Aug; 452(1-2):270-5. PubMed ID: 23727140
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Probing drug solubilization patterns in the gastrointestinal tract after administration of lipid-based delivery systems: a phase diagram approach.
    Kossena GA; Charman WN; Boyd BJ; Dunstan DE; Porter CJ
    J Pharm Sci; 2004 Feb; 93(2):332-48. PubMed ID: 14705191
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Using a selective cadmium-binding peplipid to create responsive liquid crystalline nanomaterials.
    Liu Q; Wang J; Dong YD; Boyd BJ
    J Colloid Interface Sci; 2015 Jul; 449():122-9. PubMed ID: 25554088
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Development of a high-throughput in vitro intestinal lipolysis model for rapid screening of lipid-based drug delivery systems.
    Mosgaard MD; Sassene P; Mu H; Rades T; Müllertz A
    Eur J Pharm Biopharm; 2015 Aug; 94():493-500. PubMed ID: 26159837
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Floating lipid beads for the improvement of bioavailability of poorly soluble basic drugs: in-vitro optimization and in-vivo performance in humans.
    Abouelatta SM; Aboelwafa AA; Khalil RM; ElGazayerly ON
    Eur J Pharm Biopharm; 2015 Jan; 89():82-92. PubMed ID: 25448073
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A Novel Phytantriol-Based In Situ Liquid Crystal Gel for Vaginal Delivery.
    Jie H; Liu L; Shuangying G; Xingqi W; Rongfeng H; Yong Z; Chunling T; Mengqiu X; Xiaoqin C
    AAPS PharmSciTech; 2019 May; 20(5):185. PubMed ID: 31062112
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Drug solubilization behavior during in vitro digestion of suspension formulations of poorly water-soluble drugs in triglyceride lipids.
    Kaukonen AM; Boyd BJ; Charman WN; Porter CJ
    Pharm Res; 2004 Feb; 21(2):254-60. PubMed ID: 15032306
    [TBL] [Abstract][Full Text] [Related]  

  • 59. 'Stealth' lipid-based formulations: poly(ethylene glycol)-mediated digestion inhibition improves oral bioavailability of a model poorly water soluble drug.
    Feeney OM; Williams HD; Pouton CW; Porter CJ
    J Control Release; 2014 Oct; 192():219-27. PubMed ID: 25058571
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Lyotropic Liquid-Crystalline Nanosystems as Drug Delivery Agents for 5-Fluorouracil: Structure and Cytotoxicity.
    Astolfi P; Giorgini E; Gambini V; Rossi B; Vaccari L; Vita F; Francescangeli O; Marchini C; Pisani M
    Langmuir; 2017 Oct; 33(43):12369-12378. PubMed ID: 29023126
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.